Skip to main content
. 2023 May 1;15:327–335. doi: 10.2147/BCTT.S407896

Table 1.

Characteristics of the Patients at Diagnosis

Variable HER2-Low (n = 561) HER2-0 (n = 132) Total P value
Age 48 (20–72) 49 (26–70) 48 (20–72) 0.399
Histologic type 0.431
Invasive ductal carcinoma 543 (96.79%) 126 (95.45%) 669
Other 18 (3.21%) 6 (4.55%) 24
T 0.444
 T1 61 (10.87%) 10 (7.58%) 71
 T2 385 (68.63%) 97 (73.48%) 482
 T3 115 (20.50%) 25 (18.94%) 140
N 0.008
 N0 205 (36.54%) 58 (43.94%) 263
 N1 271 (48.31%) 47 (35.61%) 318
 N2 74 (13.19%) 19 (14.39%) 93
 N3 11 (1.96%) 8 (6.06%) 19
ER 0.007
 ≤ 10 200 (45.65%) 64 (48.48%) 264
 > 10 361 (64.35%) 68 (51.52%) 429
PR 0.018
 ≤ 10 314 (55.97%) 89 (67.42%) 403
 > 10 247 (44.03%) 43 (32.58%) 290
HR 0.007
 HR+ 397 (70.77%) 77 (58.33) 474
 HR- 164 (29.23%) 55 (41.67%) 219
Ki67 0.253
 ≤ 20 290 (51.69%) 58 (43.94%) 348
 21–30 128 (22.82%) 33 (25.00%) 161
 > 30 143 (25.49%) 41 (31.06%) 184
p53 0.384
 ≤ 17.5 284 (50.62%) 73 (55.30%) 357
 > 17.5 277 (49.38%) 59 (44.70%) 336
pCR 0.468
 pCR 68 (12.12%) 19 (14.39%) 87
 Non-pCR 493 (87.88) 113 (85.61%) 606